{
    "root": "97e56e65-561c-4d0c-8a8e-86ac07173303",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Sertraline",
    "value": "20250226",
    "ingredients": [
        {
            "name": "SERTRALINE HYDROCHLORIDE",
            "code": "UTI8907Y6X"
        },
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "VANILLIN",
            "code": "CHI530446X"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "indications": "sertraline hydrochloride tablets indicated treatment following [ ( 14 ) ] : \u2022major depressive disorder ( mdd ) \u2022obsessive-compulsive disorder ( ocd ) \u2022panic disorder ( pd ) \u2022posttraumatic stress disorder ( ptsd ) \u2022social anxiety disorder ( sad ) \u2022premenstrual dysphoric disorder ( pmdd )",
    "contraindications": "indication starting maximum mdd ( 2.1 ) 50 mg per day 200 mg per day ocd ( 2.1 ) 25 mg per day ( ages 6 12 ) 200 mg per day 50 mg per day ( ages \u2265 13 ) pd , ptsd , sad ( 2.1 ) 25 mg per day 200 mg per day pmdd ( 2.2 ) continuous dosing 50 mg per day 150 mg per day pmdd ( 2.2 ) intermittent dosing 50 mg per day luteal phase 100 mg per day luteal phase \u2022 inadequate response starting , titrate 25 50 mg per day increments weekly mdd , ocd , pd , ptsd , sad ( 2.1 ) \u2022 full prescribing information titration pmdd ( 2.2 ) \u2022 hepatic impairment : mild : recommended starting maximum half recommended ( 2.4 ) moderate severe : recommended ( 2.4 ) \u2022 discontinuing sertraline hydrochloride tablets , reduce dose gradually ( 2.6 , 5.4 )",
    "warningsAndPrecautions": "sertraline hydrochloride tablets usp , 50 mg blue colored , capsule shaped , biconvex , film-coated tablets , debossed ' l ' ' u ' either side breakline one side 'd02 ' side . overbagged 10 film-coated tablets per bag , ndc 55154-3569-0 sertraline hydrochloride tablets usp , 100 mg yellow colored , capsule shaped , biconvex , film-coated tablets , debossed ' l ' ' u ' either side breakline one side 'd03 ' side . overbagged 10 film-coated tablets per bag , ndc 55154-3570-0 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "sertraline hydrochloride tablets contraindicated patients : \u2022taking , within 14 days stopping , maois , ( including maois linezolid intravenous methylene blue ) increased risk serotonin syndrome [ ( 5.2 ) , ( 7.1 ) ] . \u2022taking pimozide [ ( 7.1 ) ] . \u2022with known hypersensitivity sertraline ( e.g . , anaphylaxis , angioedema ) [ ( 6.1 , 6.2 ) ] .",
    "indications_original": "Sertraline hydrochloride tablets are indicated for the treatment of the following [See Clinical Studies (14)]:\n                  \n                     \n                        \u2022Major      depressive disorder (MDD)\n                     \n                        \u2022Obsessive-compulsive      disorder (OCD)\n                     \n                        \u2022Panic disorder      (PD)\n                     \n                        \u2022Posttraumatic      stress disorder (PTSD)\n                     \n                        \u2022Social anxiety      disorder (SAD)\n                     \n                        \u2022Premenstrual dysphoric disorder (PMDD)",
    "contraindications_original": "Indication Starting\u00a0Dosage Maximum\u00a0Dosage MDD\u00a0(2.1) 50\u00a0mg\u00a0per\u00a0day 200\u00a0mg\u00a0per\u00a0day OCD\u00a0(2.1) 25\u00a0mg\u00a0per\u00a0day\u00a0(ages\u00a06\u00a0to\u00a012) 200\u00a0mg\u00a0per\u00a0day 50\u00a0mg\u00a0per\u00a0day\u00a0(ages\u00a0\u2265\u00a013) PD,\u00a0PTSD,\u00a0SAD\u00a0(2.1) 25\u00a0mg\u00a0per\u00a0day 200\u00a0mg\u00a0per\u00a0day PMDD\u00a0(2.2)\u00a0continuous\u00a0dosing 50\u00a0mg\u00a0per\u00a0day 150\u00a0mg\u00a0per\u00a0day PMDD\u00a0(2.2)\u00a0intermittent\u00a0dosing 50\u00a0mg\u00a0per\u00a0day\u00a0during\u00a0luteal\u00a0phase\u00a0only 100\u00a0mg\u00a0per\u00a0day\u00a0during\u00a0luteal\u00a0phase\u00a0only \u2022 If inadequate response to starting dosage, titrate in 25 to 50 mg per day increments once weekly in MDD, OCD, PD, PTSD, and SAD ( 2.1 ) \u2022 See Full Prescribing Information for titration in PMDD ( 2.2 ) \u2022 Hepatic impairment: o Mild: Recommended starting and maximum dosage is half recommended dosage ( 2.4 ) o Moderate or severe: Not recommended ( 2.4 ) \u2022 When discontinuing sertraline hydrochloride tablets, reduce dose gradually ( 2.6 , 5.4 )",
    "warningsAndPrecautions_original": "Sertraline Hydrochloride Tablets USP, 50 mg\n                  \n                  Blue colored, capsule shaped, biconvex, film-coated tablets, debossed with 'L' and 'U' on either side of the breakline on one side and 'D02' on the other side.\n                  Overbagged with 10 film-coated tablets per bag, NDC 55154-3569-0\n                  \n                     Sertraline Hydrochloride Tablets USP, 100 mg\n                  \n                  Yellow colored, capsule shaped, biconvex, film-coated tablets, debossed with 'L' and 'U' on either side of the breakline on one side and 'D03' on the other side.\n                  Overbagged with 10 film-coated tablets per bag, NDC 55154-3570-0\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [See USP Controlled Room Temperature].",
    "adverseReactions_original": "Sertraline hydrochloride tablets are contraindicated in patients:\n                  \n                     \n                        \u2022Taking, or within 14 days of      stopping, MAOIs, (including the MAOIs linezolid and intravenous methylene      blue) because of an increased risk of serotonin syndrome [See Warnings      and Precautions (5.2), Drug Interactions (7.1)] .\n                     \n                        \u2022Taking pimozide [See Drug      Interactions (7.1)].\n                     \n                     \n                        \u2022With known      hypersensitivity to sertraline (e.g., anaphylaxis, angioedema) [See      Adverse Reactions (6.1, 6.2)] ."
}